| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.35T | 11.24T | 11.78T | 11.00T | 11.12T | 11.51T |
| Gross Profit | 11.35T | 11.24T | 11.78T | 11.00T | 11.12T | 11.51T |
| EBITDA | 906.16B | 1.02T | 873.96B | 923.84B | 1.10T | 980.98B |
| Net Income | 363.67B | 370.56B | 268.69B | 431.05B | 501.69B | 418.24B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 73.54T | 81.47T | 73.99T | 84.47T | 81.71T | 74.20T |
| Total Debt | 31.47T | 37.04T | 33.06T | 26.25T | 32.22T | 25.69T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 9.54T | 9.09T | 10.27T | 10.08T | 12.31T | 13.79T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.58T | -9.53T | -3.70T | 1.52T | 7.86T |
| Operating Cash Flow | 0.00 | -1.37T | -9.33T | -3.47T | 1.66T | 8.04T |
| Investing Cash Flow | 0.00 | 4.38T | -8.53T | 9.72T | 1.66T | 2.40T |
| Financing Cash Flow | 0.00 | 3.31T | 5.90T | -4.14T | 3.96T | -633.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥3.79T | 8.79 | 9.31% | 3.31% | 16.24% | 78.76% | |
71 Outperform | ¥17.29T | 10.71 | 9.14% | 2.38% | -3.62% | 23.01% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥1.76T | 12.21 | 7.83% | 2.54% | 19.38% | 29.95% | |
63 Neutral | ¥4.44T | 10.69 | 8.37% | 1.80% | 8.28% | 28.63% | |
63 Neutral | ¥9.91T | 14.35 | 5.28% | 2.73% | 2.17% | 9.55% | |
61 Neutral | ¥5.24T | 10.08 | 3.72% | 3.03% | -1.36% | 38.26% |